Literature DB >> 3090021

Construction of isogenic gonococcal strains varying in the presence of a 4.2-kilobase cryptic plasmid.

G D Biswas, J Graves, R Schwalbe, P F Sparling.   

Abstract

A 4.2-kilobase (kb) cryptic plasmid is present in 96% of isolates of Neisseria gonorrhoeae. An inability to construct isogenic derivatives which vary in the presence of the 4.2-kb plasmid has prevented the study of its function. We report a method to deliver an intact 4.2-kb plasmid into plasmidless gonococcal strains. The method involved transformation with novel 15.7-kb hybrid penicillinase-producing (Pcr) plasmids, which were cointegrates containing two copies of the 4.2-kb plasmid arranged in tandem direct repeat plus one copy of the 7.2-kb Pcr plasmid pFA3. When the 15.7-kb hybrid Pcr plasmids were introduced into a gonococcal recipient lacking evident plasmids, they dissociated at a relatively high frequency into plasmids identical to their parents: the 4.2-kb cryptic plasmid and pFA10 (a stable 11.5-kb plasmid containing one copy of each of the 7.2-kb Pcr plasmid pFA3 and the 4.2-kb cryptic plasmid pFA1). Curing strains of their Pcr plasmids resulted in isogenic strains which varied only in the presence of the 4.2-kb plasmid. The presence of the autonomously replicating 4.2-kb plasmid did not affect a number of tested phenotypes, including auxotype, antibiotic sensitivity, and frequencies of variation of outer membrane protein II. The interpretation of the functional significance of the 4.2-kb plasmid was complicated, however, by the additional finding that each of three tested plasmid-free strains contained a chromosomal fragment of about 1.6 kb that hybridized under moderate stringency with a 1.65-kb HinfI fragment of the 4.2-kb plasmid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090021      PMCID: PMC212944          DOI: 10.1128/jb.167.2.685-694.1986

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  38 in total

1.  Marker rescue transformation by linear plasmid DNA in Bacillus subtilis.

Authors:  S Contente; D Dubnau
Journal:  Plasmid       Date:  1979-10       Impact factor: 3.466

2.  A relationship between plasmid structure, structural lability, and sensitivity to site-specific endonucleases in Neisseria gonorrhoeae.

Authors:  J K Davies; S Normark
Journal:  Mol Gen Genet       Date:  1980-01

3.  Prolonged incubation in calcium chloride improves the competence of Escherichia coli cells.

Authors:  M Dagert; S D Ehrlich
Journal:  Gene       Date:  1979-05       Impact factor: 3.688

4.  Gonococci without plasmids.

Authors:  C G Copley; I Egglestone
Journal:  Lancet       Date:  1982-05-15       Impact factor: 79.321

5.  Plasmid transformation in Haemophilus influenzae.

Authors:  W L Albritton; J W Bendler; J K Setlow
Journal:  J Bacteriol       Date:  1981-02       Impact factor: 3.490

6.  Relationship between plasmid content and auxotype in Neisseria gonorrhoeae isolates.

Authors:  J R Dillon; M Pauzé
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from lactoferrin.

Authors:  P A Mickelsen; E Blackman; P F Sparling
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

8.  Human ribosomal RNA gene spacer sequences are found interspersed elsewhere in the genome.

Authors:  R Higuchi; H D Stang; J K Browne; M O Martin; M Huot; J Lipeles; W Salser
Journal:  Gene       Date:  1981-11       Impact factor: 3.688

9.  Inhibition of Neisseria gonorrhoeae isolates by Martin-Lewis medium. Epidemiology, susceptibility profile, and plasma analysis.

Authors:  M A Miller; P Anderson; J W Parker; H H Rohrer
Journal:  Br J Vener Dis       Date:  1982-04

10.  Identification of OmpR: a positive regulatory protein controlling expression of the major outer membrane matrix porin proteins of Escherichia coli K-12.

Authors:  R K Taylor; M N Hall; L Enquist; T J Silhavy
Journal:  J Bacteriol       Date:  1981-07       Impact factor: 3.490

View more
  9 in total

1.  Evaluation of a fluorescent DNA hybridization assay for the detection of Neisseria gonorrhoeae.

Authors:  R J Cano; J C Palomares; M J Torres; R E Klem
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Transformation-deficient mutants of piliated Neisseria gonorrhoeae.

Authors:  G D Biswas; S A Lacks; P F Sparling
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

Review 3.  Gene transfer in Neisseria gonorrhoeae.

Authors:  G D Biswas; S A Thompson; P F Sparling
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Cloning, sequencing, and characterization of the gene encoding FrpB, a major iron-regulated, outer membrane protein of Neisseria gonorrhoeae.

Authors:  M Beucher; P F Sparling
Journal:  J Bacteriol       Date:  1995-04       Impact factor: 3.490

5.  Interruption of the gpxA gene increases the sensitivity of Neisseria meningitidis to paraquat.

Authors:  T D Moore; P F Sparling
Journal:  J Bacteriol       Date:  1996-07       Impact factor: 3.490

6.  Evaluation of an rRNA-derived oligonucleotide probe for culture confirmation of Neisseria gonorrhoeae.

Authors:  R Rossau; M Duhamel; E Van Dyck; P Piot; H Van Heuverswyn
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Isolation of the Helicobacter pylori recA gene and involvement of the recA region in resistance to low pH.

Authors:  S A Thompson; M J Blaser
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

8.  The RTX cytotoxin-related FrpA protein of Neisseria meningitidis is secreted extracellularly by meningococci and by HlyBD+ Escherichia coli.

Authors:  S A Thompson; P F Sparling
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

9.  Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae.

Authors:  G D Biswas; P F Sparling
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.